Pediatric Cardiology • Parent Guide
The Watch-and-Wait Approach in Paediatric Cardiology
Being told to “just observe” a heart condition can feel like inaction. Here is why, in many cases, it is the smartest and safest medical decision your cardiologist can make.
📚 Moss & Adams, 10th Ed. | ACC/AHA Guidelines for Management of CHD in Adults | Rudolph’s Congenital Diseases of the Heart
👨⚕️ Pediatric Cardiology
KEY STATS
| ~30% | Many ASDs | 5–8 yr | Evidence-based |
|---|---|---|---|
| Of small VSDs close spontaneously by age 3 | Reduce in size or close without treatment | Typical age of elective ASD closure — not urgent | Watch-and-wait is guideline-recommended, not a lack of plan |
🫀 What Does “Watch and Wait” Actually Mean?
When a paediatric cardiologist recommends observation rather than immediate intervention, it is rarely because they are uncertain or being dismissive. It is usually because the evidence tells us that waiting is safer than acting.
“Watch and wait” (or expectant management or active surveillance) means:
- Regular clinical review and echocardiograms at defined intervals
- Clear pre-agreed criteria for when intervention becomes necessary
- A defined plan — not open-ended uncertainty
It is not “do nothing.” It is “do nothing surgical — while monitoring everything carefully.”
💡 Medicine’s Most Important Principle: First, Do No Harm
Every intervention — surgery, catheterisation, anaesthesia — carries risk. For a small defect that may resolve on its own or never cause symptoms, the risk of the procedure may genuinely outweigh any benefit. Watchful waiting keeps the option of intervention open while protecting the child from unnecessary procedural risk in the meantime.
Conditions Where Watch and Wait Is the Standard of Care
Small VSD (Ventricular Septal Defect)
Small VSDs create a loud murmur but cause no haemodynamic consequence — the heart size is normal, the child grows normally, and there is no strain on the lungs. Approximately 30% close spontaneously by age 3. A further proportion become smaller with age. Closure is recommended only if the defect remains significant, causes symptoms, or creates progressive cardiac enlargement.
Why not just close it? Device closure or surgery for a small VSD carries a small but real procedural risk — including arrhythmia, residual shunt, heart block, and anaesthetic risk. For a defect that is causing no problem and may close on its own, these risks are not justified.
Small ASD (Atrial Septal Defect)
Small secundum ASDs (<6–8 mm) have a reasonable chance of spontaneous closure in the first 3 years of life. Even those that don't close may not need treatment if they remain small and cause no cardiac enlargement. Elective closure is typically planned around 3–5 years — not in infancy — because:
- The child is bigger, safer for anaesthesia
- It is clear by then which ones will not close spontaneously
- The long-term risk of a small unclosed ASD only begins to accumulate in adulthood
Mild Pulmonary Stenosis
A gradient below 40 mmHg across the pulmonary valve causes no significant symptoms and rarely progresses in children with mild disease. Intervention (balloon dilation) is recommended when the gradient exceeds 50 mmHg or symptoms develop. A child with a 25 mmHg gradient may be observed indefinitely without ever needing treatment.
Mild Aortic Stenosis
Similarly, mild aortic stenosis with a gradient below 40 mmHg in an asymptomatic child with normal ventricular function is observed rather than treated. Intervention is triggered by progression of gradient, symptoms (syncope, chest pain, breathlessness), or ventricular dysfunction.
Small Persistent PDA (Patent Ductus Arteriosus) in Older Children
A tiny PDA causing no murmur and no haemodynamic effect in an older child is often left alone, particularly if its only “risk” is a very small theoretical endocarditis concern. Guidelines have moved away from routine closure of incidentally discovered silent PDAs.
What “Watching” Actually Involves
| Component | Frequency | Purpose |
|---|---|---|
| Echocardiogram | Every 6–24 months depending on condition | Measure defect size, cardiac dimensions, function, pressures |
| Clinical assessment | Each visit | Symptoms, growth, exercise tolerance |
| ECG | Periodically or if symptoms develop | Rhythm, hypertrophy patterns |
| Blood pressure (both arms) | Each visit | Relevant for aortic conditions |
| Growth chart | Each visit | Failure to thrive can indicate haemodynamic significance |
| Parental update | Each visit | New symptoms, activity changes, school performance |
The Decision Triggers — When Watching Becomes Treating
Waiting is not indefinite. Clear criteria define when intervention is indicated:
| Condition | Intervention Trigger |
|---|---|
| VSD | Cardiac enlargement (LV dilatation), pulmonary pressure elevation, failure to thrive, endocarditis episode |
| ASD | Right heart dilatation, pulmonary hypertension development, symptoms, failure to spontaneously close by 3–4 years |
| Pulmonary stenosis | Peak gradient >50 mmHg, symptoms, right ventricular dysfunction |
| Mild aortic stenosis | Gradient progression to >40–50 mmHg, LV dysfunction, symptoms |
| Bicuspid aortic valve | Aortic root dilatation to threshold, significant regurgitation or stenosis |
Your cardiologist knows exactly what they are looking for at each follow-up. The criteria are evidence-based and guideline-defined — not improvised.
⚠️ Missing Follow-Up Appointments Is the Real Risk
The danger in a watch-and-wait approach is not the watching — it is the waiting without watching. Missed echocardiograms mean missed progression. If a defect silently develops pulmonary hypertension over 3 years without anyone checking, the window for safe intervention can close. Follow-up appointments in the watch-and-wait period are not optional — they are the entire safety mechanism.
❓ Frequently Asked Questions
Q: If something is wrong with my child’s heart, why wouldn’t you fix it immediately?
Because in medicine, “fix it” always comes with a cost — the risk of the procedure itself. For a small, haemodynamically insignificant defect in a child who is growing normally and has no symptoms, the risk of the procedure genuinely exceeds any benefit. Fixing a small VSD in a 6-month-old means general anaesthesia, a catheter in the heart, a small but real risk of arrhythmia, device embolisation, or heart block — for a defect that has a 30% chance of closing on its own. The mathematics do not support immediate intervention in these cases.
Q: What if something gets worse while we’re just watching?
That is exactly what the follow-up echocardiograms are for. The entire purpose of active surveillance is to catch progression early — before it causes irreversible harm. Heart conditions almost never deteriorate suddenly without warning signs that echocardiography picks up. As long as follow-up is kept and the cardiologist’s specific warning signs are understood, watching is safe.
Q: The cardiologist said my child’s condition is “stable” — does that mean it won’t ever need treatment?
Not necessarily. “Stable” means no progression right now and no reason to intervene right now. It does not guarantee future stability. Some conditions remain stable for a lifetime; others slowly progress over years. This is why continued periodic follow-up is essential even for “stable” conditions — the goal is to catch the small number of cases that do progress before they cause harm.
Q: We are getting a second opinion because we want someone to fix it — is that wrong?
Seeking a second opinion is your right and your cardiologist should support it. However, if two independent experienced cardiologists both recommend observation for the same defect, that is very strong evidence that observation is the correct approach. What can sometimes happen is that a parent, understandably anxious, finds a doctor who agrees to intervene — but an intervention that isn’t indicated is not a favour to the child. Ask the second opinion doctor specifically: “What is the guideline recommendation for this specific defect at this specific severity, and what does the evidence say?”
Q: My child has a small VSD and the cardiologist wants to see us in 12 months — is that often enough?
For a small VSD in a child growing normally with no symptoms, a 12-month review interval is standard and appropriate. The condition does not require 3-monthly checks — that would not change management and would add unnecessary anxiety. If something changes — new symptoms, faster breathing, poor weight gain — contact the cardiologist between scheduled appointments rather than waiting.
🎯 Key Takeaways
- Watch and wait is an active, planned, evidence-based management strategy — not inaction or uncertainty.
- It is used when the risk of intervention exceeds the benefit for that defect, at that size, in that child, at that time.
- Small VSDs (~30%), small secundum ASDs, mild pulmonary stenosis, and silent small PDAs are classic conditions managed with observation.
- Follow-up echocardiograms are the safety mechanism — missing them is the real risk, not the watching.
- Clear pre-defined criteria determine when watching transitions to treating.
- If two experienced cardiologists independently recommend observation, the probability that intervention is being inappropriately withheld is very low.
📚 References & Sources
Allen HD et al. Moss & Adams’ Heart Disease in Infants, Children, and Adolescents, 10th Ed. Wolters Kluwer, 2022.
Stout KK et al. 2018 AHA/ACC Guideline for Management of Adults with Congenital Heart Disease. JACC 2019.
Rudolph AM. Congenital Diseases of the Heart, 3rd Ed. Wiley-Blackwell, 2009.
© PedHeartIndia | www.pedheartindia.com — Educational purposes only.
A note from Dr. Sunil: This article is general educational information and is not a substitute for personal medical advice. For any concern about your child’s heart, please see a qualified doctor in person.
